BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 16555088)

  • 1. Efficacy of 2-halogen substituted D-glucose analogs in blocking glycolysis and killing "hypoxic tumor cells".
    Lampidis TJ; Kurtoglu M; Maher JC; Liu H; Krishan A; Sheft V; Szymanski S; Fokt I; Rudnicki WR; Ginalski K; Lesyng B; Priebe W
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):725-34. PubMed ID: 16555088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy-D-glucose in tumor cells treated under hypoxic vs aerobic conditions.
    Maher JC; Krishan A; Lampidis TJ
    Cancer Chemother Pharmacol; 2004 Feb; 53(2):116-22. PubMed ID: 14605866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term exposure of multicellular tumor spheroids of a human glioma cell line to the glycolytic inhibitor 2-deoxy-D-glucose is more toxic than continuous exposure.
    Khaitan D; Chandna S; Dwarakanath SB
    J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S67-73. PubMed ID: 20009299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determining and understanding the control of glycolysis in fast-growth tumor cells. Flux control by an over-expressed but strongly product-inhibited hexokinase.
    Marín-Hernández A; Rodríguez-Enríquez S; Vital-González PA; Flores-Rodríguez FL; Macías-Silva M; Sosa-Garrocho M; Moreno-Sánchez R
    FEBS J; 2006 May; 273(9):1975-88. PubMed ID: 16640561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ifosfamide metabolite chloroacetaldehyde inhibits cell proliferation and glucose metabolism without decreasing cellular ATP content in human breast cancer cells MCF-7.
    Knouzy B; Dubourg L; Baverel G; Michoudet C
    J Appl Toxicol; 2010 Apr; 30(3):204-11. PubMed ID: 19774546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-inducible factor-1 confers resistance to the glycolytic inhibitor 2-deoxy-D-glucose.
    Maher JC; Wangpaichitr M; Savaraj N; Kurtoglu M; Lampidis TJ
    Mol Cancer Ther; 2007 Feb; 6(2):732-41. PubMed ID: 17308069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Deoxy-d-Glucose and Its Analogs: From Diagnostic to Therapeutic Agents.
    Pajak B; Siwiak E; Sołtyka M; Priebe A; Zieliński R; Fokt I; Ziemniak M; Jaśkiewicz A; Borowski R; Domoradzki T; Priebe W
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of cellular radiation responses by 2-deoxy-D-glucose and other glycolytic inhibitors: implications for cancer therapy.
    Kalia VK; Prabhakara S; Narayanan V
    J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S57-60. PubMed ID: 20009297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The proliferative response of hela cells to 2-deoxy-D-glucose under hypoxic or anoxic conditions: an analogue for studying some properties of in vivo solid cancers.
    Anderson KM; Tsui P; Guinan P; Rubenstein M
    Anticancer Res; 2006; 26(6B):4155-62. PubMed ID: 17201127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Under normoxia, 2-deoxy-D-glucose elicits cell death in select tumor types not by inhibition of glycolysis but by interfering with N-linked glycosylation.
    Kurtoglu M; Gao N; Shang J; Maher JC; Lehrman MA; Wangpaichitr M; Savaraj N; Lane AN; Lampidis TJ
    Mol Cancer Ther; 2007 Nov; 6(11):3049-58. PubMed ID: 18025288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential toxic mechanisms of 2-deoxy-D-glucose versus 2-fluorodeoxy-D-glucose in hypoxic and normoxic tumor cells.
    Kurtoglu M; Maher JC; Lampidis TJ
    Antioxid Redox Signal; 2007 Sep; 9(9):1383-90. PubMed ID: 17627467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibitory effect of 2-halo derivatives of D-glucose on glycolysis and on the proliferation of the human malaria parasite Plasmodium falciparum.
    van Schalkwyk DA; Priebe W; Saliba KJ
    J Pharmacol Exp Ther; 2008 Nov; 327(2):511-7. PubMed ID: 18713952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 2-deoxy-D-glucose on various malignant cell lines in vitro.
    Zhang XD; Deslandes E; Villedieu M; Poulain L; Duval M; Gauduchon P; Schwartz L; Icard P
    Anticancer Res; 2006; 26(5A):3561-6. PubMed ID: 17094483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergism of ursolic acid derivative US597 with 2-deoxy-D-glucose to preferentially induce tumor cell death by dual-targeting of apoptosis and glycolysis.
    Wang J; Jiang Z; Xiang L; Li Y; Ou M; Yang X; Shao J; Lu Y; Lin L; Chen J; Dai Y; Jia L
    Sci Rep; 2014 May; 4():5006. PubMed ID: 25833312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic antipancreatic tumor effect by simultaneously targeting hypoxic cancer cells with HSP90 inhibitor and glycolysis inhibitor.
    Cao X; Bloomston M; Zhang T; Frankel WL; Jia G; Wang B; Hall NC; Koch RM; Cheng H; Knopp MV; Sun D
    Clin Cancer Res; 2008 Mar; 14(6):1831-9. PubMed ID: 18347186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular glucose and binding of hexokinase and phosphofructokinase to particulate fractions increase under hypoxia in heart of the amazonian armored catfish (Liposarcus pardalis).
    Treberg JR; MacCormack TJ; Lewis JM; Almeida-Val VM; Val AL; Driedzic WR
    Physiol Biochem Zool; 2007; 80(5):542-50. PubMed ID: 17717817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential sensitivity to 2-deoxy-D-glucose between two pancreatic cell lines correlates with GLUT-1 expression.
    Maher JC; Savaraj N; Priebe W; Liu H; Lampidis TJ
    Pancreas; 2005 Mar; 30(2):e34-9. PubMed ID: 15714127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Deoxy-d-glucose Promotes Buforin IIb-Induced Cytotoxicity in Prostate Cancer DU145 Cells and Xenograft Tumors.
    Wanyan Y; Xu X; Liu K; Zhang H; Zhen J; Zhang R; Wen J; Liu P; Chen Y
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33297583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular metabolic responses of PET radiotracers to (188)Re radiation in an MCF7 cell line containing dominant-negative mutant p53.
    Cheon GJ; Chung HK; Choi JA; Lee SJ; Ahn SH; Lee TS; Choi CW; Lim SM
    Nucl Med Biol; 2007 May; 34(4):425-32. PubMed ID: 17499732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining radioimmunotherapy with antihypoxia therapy 2-deoxy-D-glucose results in reduction of therapeutic efficacy.
    Dearling JL; Qureshi U; Begent RH; Pedley RB
    Clin Cancer Res; 2007 Mar; 13(6):1903-10. PubMed ID: 17363547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.